|
1
|
Jiang WG, Sanders AJ, Katoh M, Ungefroren
H, Gieseler F, Prince M, Thompson SK, Zollo M, Spano D, Dhawan P,
et al: Tissue invasion and metastasis: Molecular, biological and
clinical perspectives. Semin Cancer Biol. 35 (Suppl):S244–S275.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Alizadeh AM, Shiri S and Farsinejad S.;
Metastasis review, : From bench to bedside. Tumour Biol.
35:8483–8523. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Palmer TD, Ashby WJ, Lewis JD and Zijlstra
A: Targeting tumor cell motility to prevent metastasis. Adv Drug
Deliv Rev. 63:568–581. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Slezak-Prochazka I, Durmus S, Kroesen BJ
and van den Berg A: MicroRNAs, macrocontrol: Regulation of miRNA
processing. RNA. 16:1087–1095. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kaboli PJ, Rahmat A, Ismail P and Ling KH:
MicroRNA-based therapy and breast cancer: A comprehensive review of
novel therapeutic strategies from diagnosis to treatment. Pharmacol
Res. 97:104–121. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wang Z, Wang J, Yang Y, Hao B, Wang R, Li
Y and Wu Q: Loss of has-miR-337-3p expression is associated with
lymph node metastasis of human gastric cancer. J Exp Clin Cancer
Res. 32:762013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Xiang X, Mei H, Zhao X, Pu J, Li D, Qu H,
Jiao W, Zhao J, Huang K, Zheng L and Tong Q: miRNA-337-3p
suppresses neuroblastoma progression by repressing the
transcription of matrix metalloproteinase 14. Oncotarget.
6:22452–22466. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zheng L, Jiao W, Mei H, Song H, Li D,
Xiang X, Chen Y, Yang F, Li H, Huang K and Tong Q: miRNA-337-3p
inhibits gastric cancer progression through repressing myeloid zinc
finger 1-facilitated expression of matrix metalloproteinase 14.
Oncotarget. 7:40314–40328. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Bassères DS, Tizzei EV, Duarte AA, Costa
FF and Saad ST: ARHGAP10, a novel human gene coding for a
potentially cytoskeletal Rho-GTPase activating protein. Biochem
Biophys Res Commun. 294:579–585. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Dubois T and Chavrier P: ARHGAP10, a novel
RhoGAP at the cross-road between ARF1 and Cdc42 pathways, regulates
Arp2/3 complex and actin dynamics on Golgi membranes. Med Sci
(Paris). 21:692–694. 2005.(In French). View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Bigarella CL, Borges L, Costa FF and Saad
ST: ARHGAP21 modulates FAK activity and impairs glioblastoma cell
migration. Biochim Biophys Acta. 1793:806–816. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Sousa S, Cabanes D, Archambaud C, Colland
F, Lemichez E, Popoff M, Boisson-Dupuis S, Gouin E, Lecuit M,
Legrain P and Cossart P: ARHGAP10 is necessary for alpha-catenin
recruitment at adherens junctions and for Listeria invasion. Nat
Cell Biol. 7:954–960. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
13
|
Luo N, Guo J, Chen L, Yang W, Qu X and
Cheng Z: ARHGAP10, downregulated in ovarian cancer, suppresses
tumorigenicity of ovarian cancer cells. Cell Death Dis.
7:e21572016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Li X, Xu M, Ding L and Tang J: miR-27a: A
novel biomarker and potential therapeutic target in tumors. J
Cancer. 10:2836–2848. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Li N, Xie C and Lu N: Crosstalk between
Hippo signalling and miRNAs in tumour progression. FEBS J.
284:1045–1055. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zheng LD, Jiao WJ, Mei H, Song HJ, Li D,
Xiang X, Chen YJ, Yang F, Li HH, Huang K and Tong Q: miRNA-337-3p
inhibits gastric cancer progression through repressing myeloid zinc
finger 1-facilitated expression of matrix metalloproteinase 14.
Oncotarget. 7:40314–40328. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lo SS, Hung PS, Chen JH, Tu HF, Fang WL,
Chen CY, Chen WT, Gong NR and Wu CW: Overexpression of miR-370 and
downregulation of its novel target TGFβ-RII contribute to the
progression of gastric carcinoma. Oncogene. 31:226–237. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wang M, Li C, Yu B, Su L, Li J, Ju J, Yu
Y, Gu Q, Zhu Z and Liu B: Overexpressed miR-301a promotes cell
proliferation and invasion by targeting RUNX3 in gastric cancer. J
Gastroenterol. 48:1023–1033. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Guo MM, Hu LH, Wang YQ, Chen P, Huang JG,
Lu N, He JH and Liao CG: miR-22 is down-regulated in gastric
cancer, and its overexpression inhibits cell migration and invasion
via targeting transcription factor Sp1. Med Oncol. 30:5422013.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Gu W, Zhan H, Zhou XY, Yao L, Yan M, Chen
A, Liu J, Ren X, Zhang X, Liu JX and Liu G: MicroRNA-22 regulates
inflammation and angiogenesis via targeting VE-cadherin. FEBS Lett.
591:513–526. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wang J, Zhang J, Wu J, Luo D, Su K, Shi W,
Liu J, Tian Y and Wei L: MicroRNA-610 inhibits the migration and
invasion of gastric cancer cells by suppressing the expression of
vasodilator-stimulated phosphoprotein. Eur J Cancer. 48:1904–1913.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Gao L, Ren W, Chang S, Guo B, Huang S, Li
M, Guo Y, Li Z, Song T, Zhi K and Huang C: Downregulation of
miR-145 expression in oral squamous cell carcinomas and its
clinical significance. Onkologie. 36:194–199. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Lazarini M, Traina F, Machado-Neto JA,
Barcellos KS, Moreira YB, Brandão MM, Verjovski-Almeida S, Ridley
AJ and Saad ST: ARHGAP21 is a RhoGAP for RhoA and RhoC with a role
in proliferation and migration of prostate adenocarcinoma cells.
Biochim Biophys Acta. 1832:365–374. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhang L, Luga V, Armitage SK, Musiol M,
Won A, Yip CM, Plotnikov SV and Wrana JL: A lateral signalling
pathway coordinates shape volatility during cell migration. Nat
Commun. 7:117142016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Li B, Wang L, Li Z, Wang W, Zhi X, Huang
X, Zhang Q, Chen Z, Zhang X, He Z, et al: miR-3174 contributes to
apoptosis and autophagic cell death defects in gastric cancer cells
by targeting ARHGAP10. Mol Ther Nucleic Acids. 9:294–311. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Teng JP, Yang ZY, Zhu YM, Ni D, Zhu ZJ and
Li XQ: The roles of ARHGAP10 in the proliferation, migration and
invasion of lung cancer cells. Oncol Lett. 14:4613–4618. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Barcellos KS, Bigarella CL, Wagner MV,
Vieira KP, Lazarini M, Langford PR, Machado-Neto JA, Call SG,
Staley DM, Chung JY, et al: ARHGAP21 protein, a new partner of
alpha-tubulin involved in cell-cell adhesion formation and
essential for epithelial-mesenchymal transition. J Biol Chem.
288:2179–2189. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Anthony DF, Sin YY, Vadrevu S, Advant N,
Day JP, Byrne AM, Lynch MJ, Milligan G, Houslay MD and Baillie GS:
β-Arrestin 1 inhibits the GTPase-activating protein function of
ARHGAP21, promoting activation of RhoA following angiotensin II
type 1A receptor stimulation. Mol Cell Biol. 31:1066–1075. 2011.
View Article : Google Scholar : PubMed/NCBI
|
